Functional and mechanistic advantage of the use of a bifunctional anti-PD-L1/IL-15 superagonist. Apr 16, 2020 | Merkel Cell Carcinoma, Non-Small Cell Lung Cancer
The multi-functionality of N-809, a novel fusion protein encompassing anti-PD-L1 and the IL-15 superagonist fusion complex. Nov 27, 2018 | Uncategorized
